- Recommendation ID
Decreasing pharmacological treatment:- In adults, young people and children with well-controlled asthma, what are the objective measurements and prognostic factors that indicate that a decrease in regular maintenance treatment is appropriate?
- Any explanatory notes
Why this is important:- There is consensus within the guideline committee and across healthcare professionals managing asthma that people with well-controlled asthma should not remain on high dose or multiple preventer medicines for long periods of time. However, there is little evidence available about which people might benefit most from decreasing regular maintenance therapy. This guideline identified 3 studies attempting to answer this question but none of them included a sufficiently large population, with suitable decrease in treatment throughout and assessment of multiple prognostic markers.
Source guidance details
- Comes from guidance
- Asthma: diagnosis, monitoring and chronic asthma management
- Date issued
- November 2017
|Is this a recommendation for the use of a technology only in the context of research?||No|
|Is it a recommendation that suggests collection of data or the establishment of a register?||No|